Message from Top Management トップメッセージ
Job list 職種一覧
タイトル : Oncology Medical Affairs
部署名：Medical Science & Ops div.
職務内容 : Collaborate with research, development and sales from a medical point of view to contribute to product development and product value maximization desired in the medical field.
- Lecture treatment procedures at medical sites
- Supporting sales from the perspective of science, as the core of medical communication with an emphasis on compliance.
- Medical / science activities in a wide variety of fields such as doctor led clinical trials, Publications, Advisory Board Meetings, etc.
タイトル : Clinical Scientist
部署名：New Drug and Device Development div.
職務内容 : Formulate Japan clinical development plan within global development strategy and develop clinical study protocols. Lead create CSR/CTD in oncology area also PMDA consultation related to Japan clinical development. Lead clinical studies in Japan from scientific perspective.
タイトル : Corporate Communication Manager
部署名：Strategic Planning & Ops div., Corporate Communication
職務内容 : This position will handle all communications and public relations plan to deliver the right messages, right timing. The role is expected to build relations with the Japanese media, develop media pitches and working closely with CxO team.
- Plan and execute communication strategies for corporate topics
- Expert at writing and storytelling to deliver the corporate topics to the society.
タイトル : Pharmacovigilance Manager
部署名：Product Excellence Dept. safety div.
職務内容 : This position will directly report to Safety management supervisor Japan and have responsibility for leading the execution of all Pharmacovigilance activities including re-examination properly and timely.
- Research and analysis on the events/adverse events including device deficiencies, and reports to regulatory authorities (individual cases, various periodic reports) in a timely manner.
- When the safety issue arises, lead to define the appropriate safety measurement through the communication with the related Global and external parties.